Chemistry: molecular biology and microbiology – Vector – per se
Patent
1997-08-28
1999-02-09
Guzo, David
Chemistry: molecular biology and microbiology
Vector, per se
5303873, G12N 1586, C07K 1646
Patent
active
058693319
ABSTRACT:
The present invention pertains to retroviral vector particles having target cell specificity which comprises a retroviral vector having a targeting peptide fused to the envelope protein of the retroviral vector to form a targeting envelope, wherein the targeting peptide replaces or disrupts the natural viral receptor binding site and the targeting peptide is the antigen binding site of an antibody, the receptor binding peptide of another virus, or is a peptide that specifically binds to a specific receptor of the target.
REFERENCES:
Kewalramani, V. N., et al. "Spleen Necrosis Virus, an avian innunossupressive retrovirus, shares a receptor with the type D simian retroviruses", Journal of Virology, vol. 66, No. 5, May 1992, pp. 3026-3031.
Riley, S.C. et al. "Preferential expression of variable region heavy chain gene segments by predominant 2,4-dinitrophenyl-specific BALB/c neonatal antibody clonotypes," Proceedings of the National Academy of Sciences of USA, vol. 83, No. 8, Apr. 1986, pp. 2589-2593.
Russell, S.J. et al. "Retroviral vectors displaying functional antibody fragments," Nucleic Acids Res. (1993), 21(5), pp. 1081-1085.
Te-Hua, T.C., et al. "Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins," Gene Therapy, vol. 1, No. 5, Sep. 1994, pp. 292-299.
Marshall, "Gene Therapy's Growing Pains", Science, vol. 269, 25 Aug. 1995, pp. 1050-1055.
Russell et al., "Retrovial Vectors Displaying Fuctional Antibody Fragments", Nuclear Acids Res., vol. 21, No. 5, pp. 1081-1085, 1993.
A. Duatz Miller, "Human Gene Therapy Comes of Age", Nature, vol. 357, Jun. 1992, pp. 455-460.
A. Duatz Miller, "Retrovirus Packagaing Cells", Human Gene Therapy, vol. 1, pp. 5-14, 1990.
Weiss, In "RNA Tumor Viruses", Chapter 3, pp. 226-260, Weiss et al., Eds., Cold Spring Harbor Labortory, 1984.
Guzo David
University of Medicine & Dentistry of New Jersey
LandOfFree
Cell type specific gene transfer using retroviral vectors contai does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell type specific gene transfer using retroviral vectors contai, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell type specific gene transfer using retroviral vectors contai will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1947893